DNA content as a prognostic marker in patients with oral leukoplakia (Retraction in: New England Journal of Medicine (2006) 355:18 (1927))

New England Journal of Medicine

Volumn 344, Issue 17, 2001, Pages 1270-1278

  Sudbø, Jon ^a,b   Kildal, Wanja ^a   Risberg, Björn ^a   Koppang, Hanna S ^a   Danielsen, Håvard E ^a   Reith, Albrecht ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE MARKER; DNA CONTENT; EPITHELIUM DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH HYGIENE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

BIOPSY; DNA, NEOPLASM; FOLLOW-UP STUDIES; GENETIC MARKERS; LEUKOPLAKIA, ORAL; MOUTH NEOPLASMS; PLOIDIES; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035953649     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200104263441702     Document Type: Article

References (54)

1. Leukoplakia revisited: A clinicopathologic study 3256 oral leukoplakias
2. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years
3. Oral leukoplakia and malignant transformation: A follow-up study of 257 patients
4. Epidemiologic and demographic update in oral cancer: California and national data - 1973 to 1985
5. Cancer of the base of the tongue: Past and future
6. Prognosis in mouth cancer: Turnout factors
7. Novel approaches to the prevention of head and neck cancer
8. Leukoplakia: Still a gallimaufry or is progress being made? - A review
9. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma
10. Observer variability in the histologic assessment of oral premalignant lesions
11. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
12. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity
13. Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions
14. Frequent gene deletions in potentially malignant oral lesions
15. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin
16. Lack of molecular markers to predict malignant potential of oral precancer
17. Aneuploidy and cancer
18. Chromosomal instability and cytoskeletal defects in oral cancer cells
19. The spindle checkpoint: Two transitions, two pathways
20. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation
21. Characterization of MAD2B and other mitotic spindle checkpoint genes
22. Genetic instabilities in human cancers
23. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations
24. Genomic instability in multistage carcinogenesis
25. Nuclear DNA content and p53 immunostaining in metachronous preneoplastic lesions and subsequent carcinomas of the oral cavity
26. Which oral white lesions will become malignant? An image cytometric study
27. Flow cytometric analysis of nuclear DNA content in oral leukoplakia
28. DNA analysis from paraffin-embedded blocks
29. 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I. Basic considerations and recommendations for preparation, measurement and interpretation: European Society for Analytical and Cellular Pathology
30. Erythroplakia of the oral cavity
31. Multiple head and neck tumors: Evidence for a common clonal origin
32. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions
33. Genetic progression model for head and neck cancer: Implications for field cancerization
34. Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus, and lung
35. Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers
36. Synchronous oral carcinomas: Independent or common clonal origin?
37. Co-carcinogenesis and field cancerization: Oral lesions offer first signs
38. Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience
39. The molecular genetics of cancer
40. A genetic model of colorectal tumorigenesis
41. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization
42. Aetiology of oral cancer: Alcohol
43. Genetic susceptibility to head and neck cancer: Interaction between nutrition and mutagen sensitivity
44. Genetic susceptibility to head and neck squamous cell carcinoma
45. Mutagen sensitivity in patients with head and neck cancers: A biologic marker for risk of multiple primary malignancies
46. Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland
47. Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolaevulinic acid
48. Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue
49. 13-cis-Retinoic acid in the treatment of oral leukoplakia
50. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: Improved local-regional disease control compared with surgery alone
51. Increase of tongue cancer in young men
52. Squamous cell carcinoma of the tongue in young patients: A matched-pair analysis